This is just a press release opportunity. For a product to be sold it would need to be tga approved. The low dose allowed for otc means that not only do no products from any manufacturer make the grade today it is likely none ever will as the maximum allowable dose is likely too low to demonstrate efficacy for any indication in a clinical trial
- Forums
- ASX - By Stock
- Cannabis oil firms chase approvals as over-the-counter sales are legalised
This is just a press release opportunity. For a product to be...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable